Colucid Pharmaceuticals, Inc. (CLCD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
01-Mar-17 12:22 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition 83,000$46.50$3,859,500.00(32%)
256.52K to 173.52K
01-Mar-17 3:34 PM
View: 
Pappas Arthur M
Director
10% Owner
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 1,992,890$46.50$92,669,600.00(100%)
1.99M to 0
01-Mar-17 12:29 PM
View: 
Skwierczynski Raymond
Head,Pharmaceutical Operations
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 3,615$46.50$168,098.00(100%)
3.62K to 0
01-Mar-17 12:12 PM
View: 
Dallas Matthew D
Chief Financial Officer
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition 37,500$46.50$1,743,750.00(93%)
40.21K to 2.71K
(< 1%)
01-Mar-17 12:12 PM
View: 
Dallas Matthew D
Chief Financial Officer
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 2,708$46.50$125,922.00(100%)
2.71K to 0
(< 1%)
01-Mar-17 12:20 PM
View: 
Marengere Luc
Director
10% Owner
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 1,545,390$46.50$71,860,400.00(100%)
1.55M to 0
01-Mar-17 12:22 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 173,519$46.50$8,068,630.00(100%)
173.52K to 0
01-Mar-17 12:14 PM
View: 
Kuca Bernice
Head,Clin. and Reg. Operations
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition 37,500$46.50$1,743,750.00(93%)
40.23K to 2.73K
01-Mar-17 12:14 PM
View: 
Kuca Bernice
Head,Clin. and Reg. Operations
Colucid Pharmaceuticals, Inc. (CLCD) 01-Mar-17Disposition (change in control) 2,729$46.50$126,898.00(100%)
2.73K to 0
05-Jan-17 4:37 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Jan-17Option Exercise 3,755----1%
254.27K to 258.02K
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Jan-17Market Option Sale (Planned) 1,677$34.59$58,010.60(100%)
1.68K to 0
(34%)
05-Jan-17 4:37 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Jan-17Market Option Sale (Planned) 1,502$34.78$52,237.90(< 1%)
258.02K to 256.52K
(33%)
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Jan-17Option Exercise 1,677$10.00$16,770.00100%
0 to 1.68K
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Jan-17Option Exercise 185$7.56$1,398.60100%
0 to 0.18K
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Jan-17Market Option Sale (Planned) 185$36.40$6,734.00(100%)
0.18K to 0
(27%)
04-Jan-17 4:24 PM
View: 
Dallas Matthew D
Chief Financial Officer
Colucid Pharmaceuticals, Inc. (CLCD) 03-Jan-17Market Sale (Planned) 1,473$36.25$53,396.20(4%)
41.6K to 40.13K
(28%)
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 03-Jan-17Option Exercise 718$6.75$4,846.50100%
0 to 0.72K
05-Jan-17 4:35 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 03-Jan-17Market Option Sale (Planned) 718$36.25$26,027.50(100%)
0.72K to 0
(28%)
04-Jan-17 4:25 PM
View: 
Kuca Bernice
Head,Clin. and Reg. Operations
Colucid Pharmaceuticals, Inc. (CLCD) 03-Jan-17Market Sale (Planned) 772$36.25$27,985.00(2%)
40.86K to 40.09K
(28%)
05-Dec-16 4:39 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Dec-16Market Option Sale (Planned) 1,864$38.75$72,230.00(100%)
1.86K to 0
(15%)
05-Dec-16 4:39 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Dec-16Option Exercise 1,864$9.76$18,186.20100%
0 to 1.86K
05-Dec-16 4:41 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Dec-16Option Exercise 3,756----1%
252.01K to 255.77K
05-Dec-16 4:41 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Dec-16Market Option Sale (Planned) 1,502$38.75$58,202.50(< 1%)
255.77K to 254.27K
(15%)
01-Dec-16 4:45 PM
View: 
Kuca Bernice
Head,Clin. and Reg. Operations
Colucid Pharmaceuticals, Inc. (CLCD) 01-Dec-16Market Sale (Planned) 772$35.22$27,190.00(2%)
41.63K to 40.86K
(26%)
05-Dec-16 4:39 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 01-Dec-16Option Exercise 719$6.75$4,853.25100%
0 to 0.72K
01-Dec-16 4:43 PM
View: 
Dallas Matthew D
Chief Financial Officer
Colucid Pharmaceuticals, Inc. (CLCD) 01-Dec-16Market Sale (Planned) 1,473$35.17$51,801.10(3%)
43.07K to 41.6K
(26%)
05-Dec-16 4:39 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 01-Dec-16Market Option Sale (Planned) 719$35.22$25,322.50(100%)
0.72K to 0
(26%)
07-Nov-16 4:24 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 07-Nov-16Option Exercise 1,677$10.00$16,770.00100%
0 to 1.68K
07-Nov-16 4:24 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 07-Nov-16Market Option Sale (Planned) 1,677$28.52$47,830.10(100%)
1.68K to 0
(46%)
07-Nov-16 4:26 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 07-Nov-16Market Option Sale (Planned) 1,502$28.57$42,916.90(< 1%)
250.42K to 248.92K
(46%)
07-Nov-16 4:26 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Nov-16Option Exercise 3,755----2%
246.67K to 250.42K
07-Nov-16 4:24 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Nov-16Market Option Sale (Planned) 185$28.95$5,355.75(100%)
0.18K to 0
(44%)
07-Nov-16 4:24 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Nov-16Option Exercise 185$7.56$1,398.60100%
0 to 0.18K
01-Nov-16 4:28 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 01-Nov-16Option Exercise 719$6.75$4,853.25100%
0 to 0.72K
01-Nov-16 4:28 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 01-Nov-16Market Option Sale (Planned) 719$30.00$21,570.00(100%)
0.72K to 0
(39%)
05-Oct-16 4:19 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Oct-16Option Exercise 3,755----2%
244.41K to 248.17K
05-Oct-16 4:19 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 05-Oct-16Market Option Sale (Planned) 1,502$37.08$55,694.20(< 1%)
248.17K to 246.67K
(12%)
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Oct-16Market Option Sale (Planned) 1,677$37.08$62,183.20(100%)
1.68K to 0
(12%)
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 05-Oct-16Option Exercise 1,677$10.00$16,770.00100%
0 to 1.68K
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Oct-16Market Option Sale (Planned) 185$36.41$6,735.85(100%)
0.18K to 0
(14%)
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 04-Oct-16Option Exercise 185$7.56$1,398.60100%
0 to 0.18K
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 03-Oct-16Option Exercise 719$6.75$4,853.25100%
0 to 0.72K
05-Oct-16 4:17 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 03-Oct-16Market Option Sale (Planned) 719$37.74$27,135.10(100%)
0.72K to 0
(10%)
16-Sep-16 4:45 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 14-Sep-16Market Sale (Planned) 6,000$23.32$139,946.00(2%)
250.41K to 244.41K
(79%)
13-Sep-16 4:27 PM
View: 
Domain Partners Vi, L.P.
10% Owner
Colucid Pharmaceuticals, Inc. (CLCD) 09-Sep-16Disposition (other) 1,943,110----(100%)
1.94M to 0
13-Sep-16 11:48 AM
View: 
Novo A/s
10% Owner
Colucid Pharmaceuticals, Inc. (CLCD) 09-Sep-16Private Purchase 100,000$20.00$2,000,000.003%
3.06M to 3.16M
07-Sep-16 5:56 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 07-Sep-16Market Option Sale (Planned) 2,254$22.38$50,454.90(< 1%)
255.41K to 253.16K
(86%)
07-Sep-16 5:56 PM
View: 
Mathers Thomas P.
Chief Executive Officer
Director
Colucid Pharmaceuticals, Inc. (CLCD) 07-Sep-16Market Sale (Planned) 2,746$22.38$61,468.10(1%)
253.16K to 250.41K
(86%)
07-Sep-16 5:59 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 06-Sep-16Market Option Sale (Planned) 45,001$19.91$895,780.00(92%)
48.74K to 3.73K
(109%)
07-Sep-16 5:59 PM
View: 
Hogan Linda C.
Head, Bus. Dev. and Strategy
Colucid Pharmaceuticals, Inc. (CLCD) 06-Sep-16Market Option Sale (Planned) 3,735$19.50$72,832.50(100%)
3.73K to 0
(114%)